Us Interventional Oncology Ablation Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Interventional Oncology Ablation Market was valued at USD 4.6 Billion in 2022 and is projected to reach USD 8.1 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The U.S. Interventional Oncology Ablation Market is experiencing significant growth, driven by the increasing prevalence of cancer and the rising demand for minimally invasive treatment options. Interventional oncology focuses on diagnosing and treating cancer through image-guided, minimally invasive procedures, with ablation therapies being a cornerstone of this approach. **Market Overview** In 2023, the global interventional oncology market was valued at approximately USD 2.02 billion and is projected to reach USD 4.04 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8% during the forecast period. citeturn0search3 The U.S. market, a significant contributor to this growth, is expected to mirror these trends, with a projected market size of USD 2.75 billion by 2024 and USD 4.24 billion by 2029, reflecting a robust CAGR of 9.0%. citeturn0search2 **Key Drivers** - **Rising Cancer Incidence**: The increasing number of cancer cases in the U.S. is a primary driver. For instance, in 2020, there were 1,603,844 new cancer cases and 602,347 cancer-related deaths in the U.S. citeturn0search3 - **Advancements in Minimally Invasive Techniques**: Technological innovations have enhanced the efficacy and safety of interventional oncology procedures, making them more appealing to both patients and healthcare providers. - **Patient Preference for Outpatient Procedures**: Minimally invasive procedures often allow for outpatient treatment, reducing hospital stays and associated costs, which is favorable for patients and healthcare systems alike. **Market Segmentation** - **By Product Type**: Ablation devices, including radiofrequency ablation, microwave ablation, and cryoablation, dominate the market. In 2023, ablation devices held a 35% market share. citeturn0search1 - **By Procedure**: Radioembolization, accounting for 29% of the market share, is a significant procedure in interventional oncology. citeturn0search1 - **By Indication**: Liver cancer holds a substantial market share, reflecting the high incidence and the effectiveness of interventional oncology treatments for this type of cancer. citeturn0search1 - **By End-Use**: Hospitals are the primary end-users, accounting for 60% of the market share, due to their capacity to provide comprehensive cancer care services. citeturn0search1 **Competitive Landscape** The U.S. interventional oncology ablation market is characterized by the presence of several key players, including: - **Boston Scientific Corporation** - **Johnson & Johnson** - **Medtronic Plc** - **Varian Medical Systems** - **EDAP TMS S.A.** These companies are actively involved in developing and marketing advanced interventional oncology devices and therapies. **Regional Insights** North America, particularly the U.S., holds a dominant position in the interventional oncology market, attributed to advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of key market players. citeturn0search3 **Future Outlook** The U.S. interventional oncology ablation market is expected to continue its upward trajectory, driven by technological advancements, an aging population, and increasing patient awareness of minimally invasive treatment options. The integration of interventional oncology into standard cancer care protocols is anticipated to further bolster market growth.
Get an In-Depth Research Analysis of the Global Interventional Oncology Ablation Market Size And Forecast [2025-2032]
Â
Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems
Inc.
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems
Inc.
STARmed Co.
Biomedical Srl
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Interventional Oncology Ablation Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Interventional Oncology Ablation Market
Radiofrequency Ablation (RFA)
Microwave Ablation (MWA)
Cryoablation
Laser Ablation
High-Intensity Focused Ultrasound (HIFU)
Oncology Treatment
Palliative Care
Tumor Ablation
Hospitals
Ambulatory Surgical Centers (ASCs)
Specialized Cancer Treatment Centers
Research Institutions
Invasive Modalities
Non-Invasive Modalities
Minimally Invasive Modalities
Devices
Consumables
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Interventional Oncology Ablation Market Research Analysis
1. Introduction of the Global Interventional Oncology Ablation Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Interventional Oncology Ablation Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Interventional Oncology Ablation Market, By Type
6. Global Interventional Oncology Ablation Market, By Application
7. Global Interventional Oncology Ablation Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Interventional Oncology Ablation Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/